Lytix Biopharma AS (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 9.32
-0.04 (-0.43%)
Aug 25, 2025, 4:25 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 638.93 million as of August 25, 2025. Its market cap has increased by 18.16% in one year.
Market Cap
638.93M
Enterprise Value
523.91M
Revenue
608.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
9.32
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 720.55M to 638.93M, a decrease of -11.33%. That is a compound annual growth rate of -2.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 636.20M | 58.50% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | 720.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.81B |
| Nordhealth AS | 2.90B |
| Photocure ASA | 1.65B |
| ArcticZymes Technologies ASA | 1.50B |
| Vistin Pharma ASA | 1.06B |
| Omda AS | 1.02B |
| Thor Medical ASA | 960.12M |
| Gentian Diagnostics ASA | 879.07M |